Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $1.33 | Prev. Close $1.29 | Circuit Range N/A |
Day Range $1.29 - $1.33 | Year Range $0.05 - $11.92 | Volume 457 |
Average Traded $1.32 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $1.33 | $1.29 | -2.27% |
05-Feb-26 | $1.39 | $1.32 | -16.46% |
04-Feb-26 | $1.58 | $1.58 | -2.77% |
03-Feb-26 | $1.73 | $1.63 | -3.85% |
02-Feb-26 | $1.84 | $1.69 | -21.03% |
30-Jan-26 | $1.52 | $2.14 | +45.58% |
29-Jan-26 | $1.55 | $1.47 | -9.54% |